Incorporating Pharmacogenomics in Clinical Studies
info
September 25 - September 26 2006 | Hyatt Regency Baltimore | Baltimore, MD
title
Why You Should Attend
Why You Should Attend
Clinical Pharmacogenomic Trial Design: • How to improve drug development success through Pharmacogenomics • Gain insight into why to incorporate pharmacogenomics into clinical studies • Learn from the leaders in the industry who have successful used biomarkers and diagnostics through development and the clinic • Determine the challenges to success and strategies to overcome these • Outsource clinical trials pharmacogenomic sample preparation, management and testing
Design Pharmacogenomic Assays • Build knowledge in the practical applications pharmacogenomics and diagnostics • Learn from the leaders in the industry who have successful used biomarkers and diagnostics through development and the clinic • Evaluate methods for RNA extraction and validation of the affymetrix microarrayplatform for clinical Application • Understand the development of an assay for detection of DNA-sequence variation in a comprehensive set of genes implicated Analytical in drug metabolism and clearance
Design Regulatory strategies • Assess the clinical value of pharmacogenomic data and how to submit that data • Clarify the regulatory requirements for diagnostic co development • Learn how to comply with FDA requirements for genomics in clinical studies
The Institute for International Research works with many accreditation boards such as NASBA, ACPE, CLE, and the Thomas Beam Institute, to give you the opportunity to receive continuing education credits. To learn more about accreditations, contact La Shawn Jackson, the Continuing Education Coordinator, at ljackson@iirusa.com.
